Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14519) 14519
Newspaper Article (2081) 2081
Newsletter (564) 564
Book Chapter (362) 362
Magazine Article (270) 270
Web Resource (35) 35
Book / eBook (34) 34
Trade Publication Article (33) 33
Transcript (17) 17
Reference (10) 10
Conference Proceeding (8) 8
Book Review (3) 3
Dissertation (3) 3
Streaming Video (2) 2
Government Document (1) 1
Paper (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11876) 11876
migraine (11533) 11533
science & technology (8943) 8943
life sciences & biomedicine (8803) 8803
migraine disorders - drug therapy (7408) 7408
female (6471) 6471
neurosciences & neurology (5853) 5853
clinical neurology (5666) 5666
male (5339) 5339
adult (5177) 5177
middle aged (3817) 3817
headache (3262) 3262
neurology (3257) 3257
biological and medical sciences (2835) 2835
medical sciences (2817) 2817
neurosciences (2801) 2801
headaches (2572) 2572
drug therapy (2294) 2294
adolescent (2105) 2105
pain (1988) 1988
treatment outcome (1872) 1872
migraine disorders - physiopathology (1865) 1865
pharmacology. drug treatments (1747) 1747
medicine & public health (1570) 1570
aged (1539) 1539
migraine disorders - diagnosis (1464) 1464
migraine disorders - prevention & control (1368) 1368
vascular diseases and vascular malformations of the nervous system (1358) 1358
care and treatment (1341) 1341
clinical trials (1259) 1259
animals (1233) 1233
abridged index medicus (1193) 1193
research (1193) 1193
child (1113) 1113
serotonin receptor agonists - therapeutic use (1107) 1107
nervous system (1093) 1093
pharmacology & pharmacy (1086) 1086
migraine disorders - therapy (1084) 1084
double-blind method (1047) 1047
cardiovascular system (1044) 1044
patients (1021) 1021
migraine disorders - complications (973) 973
migraine disorders - epidemiology (956) 956
analgesics - therapeutic use (930) 930
risk factors (925) 925
vasodilator agents. cerebral vasodilators (919) 919
migraine disorders - etiology (918) 918
internal medicine (912) 912
young adult (884) 884
general & internal medicine (870) 870
analysis (857) 857
medicine, general & internal (855) 855
pain medicine (808) 808
pharmaceutical industry (765) 765
sumatriptan - therapeutic use (746) 746
psychiatry (708) 708
chronic disease (706) 706
sumatriptan (705) 705
medical research (673) 673
time factors (664) 664
health aspects (646) 646
headache - drug therapy (635) 635
quality of life (634) 634
drugs (628) 628
acute disease (626) 626
analgesics (625) 625
tryptamines - therapeutic use (612) 612
studies (608) 608
medicine (606) 606
prevention (603) 603
clinical trials as topic (595) 595
chronic migraine (573) 573
dose-response relationship, drug (553) 553
comorbidity (547) 547
diagnosis (543) 543
diagnosis, differential (538) 538
neuropharmacology (529) 529
retrospective studies (511) 511
pediatrics (504) 504
prospective studies (500) 500
tryptamines (499) 499
anti-inflammatory agents, non-steroidal - therapeutic use (498) 498
fda approval (481) 481
migraine disorders - psychology (480) 480
drug dosages (479) 479
surveys and questionnaires (472) 472
migraine disorders - metabolism (469) 469
headache. facial pains. syncopes. epilepsia. intracranial hypertension. brain oedema. cerebral palsy (465) 465
medicine, experimental (453) 453
research article (434) 434
ergotamine - therapeutic use (423) 423
prevalence (421) 421
serotonin receptor agonists - adverse effects (420) 420
sumatriptan - administration & dosage (416) 416
anticonvulsants - therapeutic use (415) 415
randomized controlled trials as topic (410) 410
follow-up studies (406) 406
neurosurgery (405) 405
recurrence (404) 404
pain measurement (400) 400
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (13) 13
Online Resources - Online (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16586) 16586
German (516) 516
French (271) 271
Spanish (206) 206
Japanese (91) 91
Italian (85) 85
Russian (74) 74
Polish (61) 61
Portuguese (53) 53
Danish (50) 50
Norwegian (38) 38
Chinese (31) 31
Dutch (29) 29
Swedish (23) 23
Hungarian (17) 17
Finnish (14) 14
Serbian (9) 9
Turkish (8) 8
Czech (7) 7
Romanian (6) 6
Croatian (5) 5
Lithuanian (3) 3
Persian (3) 3
Ukrainian (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Hebrew (1) 1
Hindi (1) 1
Icelandic (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Issues related to symptomatic and disease‐modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy
by Brooks‐Kayal, Amy R and Bath, Kevin G and Berg, Anne T and Galanopoulou, Aristea S and Holmes, Gregory L and Jensen, Frances E and Kanner, Andres M and O'Brien, Terence J and Whittemore, Vicky H and Winawer, Melodie R and Patel, Manisha and Scharfman, Helen E
Epilepsia (Copenhagen), ISSN 0013-9580, 08/2013, Volume 54, Issue 4, pp. 44 - 60
Biomarkers | Therapy | Animal models | Comorbidity | Epilepsy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Drugs, Investigational - adverse effects | Cognition Disorders - chemically induced | Humans | Drugs, Investigational - therapeutic use | Depressive Disorder - drug therapy | Neurocognitive Disorders - psychology | Anxiety Disorders - chemically induced | Migraine Disorders - chemically induced | Neurocognitive Disorders - drug therapy | Depressive Disorder - chemically induced | Quality of Life - psychology | Anxiety Disorders - drug therapy | Drug Evaluation, Preclinical | Cognition Disorders - psychology | Disease Models, Animal | Attention Deficit Disorder with Hyperactivity - chemically induced | Epilepsy - psychology | Translational Medical Research | Neurocognitive Disorders - diagnosis | Neurocognitive Disorders - chemically induced | Cognition Disorders - drug therapy | Anxiety Disorders - psychology | Attention Deficit Disorder with Hyperactivity - drug therapy | Drug Discovery | Migraine Disorders - drug therapy | Epilepsy - diagnosis | Cognition Disorders - diagnosis | Animals | Migraine Disorders - psychology | Attention Deficit Disorder with Hyperactivity - psychology | Epilepsy - drug therapy | Depressive Disorder - psychology | Analysis | Medical research | Quality of life | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Antiepileptic drugs in non-epilepsy disorders: Relations between mechanisms of action and clinical efficacy
by Johannessen Landmark, Cecilie
CNS drugs, ISSN 1172-7047, 2008, Volume 22, Issue 1, pp. 27 - 47
Migraine | Schizophrenia | Anxiety | Antiepileptic drugs, general | Bipolar disorders | Essential tremor | Neuropathic pain | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Mental Disorders - drug therapy | Pain - drug therapy | Humans | Nervous System Diseases - drug therapy | Anticonvulsants - therapeutic use | Anxiety - drug therapy | Nervous System Diseases - physiopathology | Schizophrenia - drug therapy | Essential Tremor - drug therapy | Anticonvulsants - pharmacology | Bipolar Disorder - drug therapy | Migraine Disorders - drug therapy | Drugs | Headache | Drug abuse | Mental disorders | Gabapentin | Epilepsy | Clinical trials | Bipolar disorder | Intracellular signalling | Alcohol | Neuropathy | Antiepileptic agents | Cancer therapies | Fear & phobias | Signal transduction | Pain | Rodents | Human immunodeficiency virus--HIV | Ion channels | Neurological disorders | Calcium channels | Calcium channels (voltage-gated) | Excitability | Etiracetam | Carbamazepine | Asthma | Bulimia | Mood | Post traumatic stress disorder | Anxieties | Cocaine | Glutamatergic transmission | Intracellular | Neurotransmission
Journal Article
Details down arrow
3. Full Text Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety
by Blumenfeld, Andrew M and Tepper, Stewart J and Robbins, Lawrence D and Manack Adams, Aubrey and Buse, Dawn C and Orejudos, Amelia and D Silberstein, Stephen
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 03/2019, Volume 90, Issue 3, pp. 353 - 360
sleep | anxiety | fatigue | depression | comorbidities | onabotulinumtoxinA | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Prospective Studies | Drug Administration Schedule | Sleep Wake Disorders - drug therapy | Fatigue - drug therapy | Humans | Depressive Disorder - diagnosis | Anxiety Disorders - diagnosis | Fatigue - etiology | Depressive Disorder - drug therapy | Male | Sleep Wake Disorders - diagnosis | Treatment Outcome | Fatigue - diagnosis | Neuromuscular Agents - therapeutic use | Depressive Disorder - etiology | Anxiety Disorders - etiology | Migraine Disorders - drug therapy | Botulinum Toxins, Type A - therapeutic use | Migraine Disorders - psychology | Adult | Female | Anxiety Disorders - drug therapy | Chronic Disease | Sleep Wake Disorders - etiology | Mental disorders | Comorbidity | Migraine | Feasibility studies | Headaches | Clinical trials | Fatigue | Mental depression | Botulinum toxin | Quality of life | Sleep | Pain | Anxieties | Index Medicus | 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders—a pharmacoepidemiological study and clinical implications
by Baftiu, Arton and Johannessen Landmark, Cecilie and Rusten, Ida Rudberg and Feet, Silje Andrea and Johannessen, Svein I and Larsson, Pål G
European journal of clinical pharmacology, ISSN 0031-6970, 10/2016, Volume 72, Issue 10, pp. 1245 - 1254
Pharmacoepidemiology | Biomedicine | Epilepsy | Norwegian Prescription Database (NorPD) | Non-epilepsy indications | Retention rates | Pharmacovigilance | Pharmacology/Toxicology | Antiepileptic drugs | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Humans | Middle Aged | Anticonvulsants - therapeutic use | Child, Preschool | Infant | Male | Practice Patterns, Physicians | Migraine Disorders - drug therapy | Neuralgia - drug therapy | Young Adult | Medication Adherence | Mental Disorders - drug therapy | Norway | Adolescent | Aged, 80 and over | Adult | Epilepsy - drug therapy | Female | Aged | Child | Drug Utilization - statistics & numerical data | Infant, Newborn | Drugs | Medical research | Anticonvulsants | Pharmacy | Medicine, Experimental | Drug therapy | Studies | Databases | Epidemiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection
by Vamos, Eniko and Pardutz, Arpad and Klivenyi, Peter and Toldi, Jozsef and Vecsei, Laszlo
Journal of the neurological sciences, ISSN 0022-510X, 2009, Volume 283, Issue 1, pp. 21 - 27
Neurology | Neurological disorders | Central nervous system | Kynurenine pathway | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Receptors, Glutamate - metabolism | Brain Diseases - metabolism | Kynurenine - therapeutic use | Humans | Brain Ischemia - metabolism | Epilepsy - metabolism | Parkinson Disease - drug therapy | Neurodegenerative Diseases - drug therapy | Pain - metabolism | Migraine Disorders - metabolism | Brain - metabolism | Brain Diseases - drug therapy | Pain - drug therapy | Parkinson Disease - metabolism | Kynurenine - metabolism | Huntington Disease - drug therapy | Multiple Sclerosis - metabolism | Signal Transduction | Alzheimer Disease - drug therapy | Neurodegenerative Diseases - metabolism | Huntington Disease - metabolism | Migraine Disorders - drug therapy | Animals | Brain Ischemia - drug therapy | Alzheimer Disease - metabolism | Epilepsy - drug therapy | Multiple Sclerosis - drug therapy | Phosphates | Methyl aspartate | Nervous system diseases | Neurosciences | Parkinson's disease | Huntington's chorea | Tryptophan | HIV (Viruses) | Health aspects | Alzheimer's disease | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression
by De Berardis, Domenico and Fornaro, Michele and Serroni, Nicola and Campanella, Daniela and Rapini, Gabriella and Olivieri, Luigi and Srinivasan, Venkataramanujam and Iasevoli, Felice and Tomasetti, Carmine and De Bartolomeis, Anea and Valchera, Alessano and Perna, Giampaolo and Mazza, Monica and Di Nicola, Marco and Martinotti, Giovanni and Di Giannantonio, Massimo
International journal of molecular sciences, ISSN 1422-0067, 01/2015, Volume 16, Issue 1, pp. 1111 - 1130
schizophrenia | melatonergic receptors | agomelatine | bipolar depression | anxiety | serotonin | alcohol dependence | fibromyalgia | noradrenaline | melatonin | migraines | dopamine | seasonal affective disorder | psychiatric disorders | Seasonal affective disorder | Melatonin | Dopamine | Serotonin | Fibromyalgia | Schizophrenia | Alcohol dependence | Bipolar depression | Migraines | Melatonergic receptors | Agomelatine | Anxiety | Noradrenaline | Psychiatric disorders | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Acetamides - pharmacokinetics | Sleep Wake Disorders - drug therapy | Humans | Receptor, Serotonin, 5-HT2C - metabolism | Depressive Disorder - drug therapy | Bipolar Disorder - drug therapy | Migraine Disorders - drug therapy | Antidepressive Agents - therapeutic use | Acetamides - therapeutic use | Fibromyalgia - drug therapy | Receptor, Serotonin, 5-HT2C - chemistry | Schizophrenia - drug therapy | Antidepressive Agents - pharmacokinetics | Receptor, Melatonin, MT2 - metabolism | Receptor, Melatonin, MT1 - metabolism | Psychological aspects | Antidepressants | Anxieties | Mental depression | Drug use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights